Products for Research Use Only

RecombinantEGF, Mouse

CAT: 0013-GTR18991868-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR18991868-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Epidermal Growth Factor (EGF) was originally discovered in crude preparations of nerve growth factor prepared from mouse submaxillary glands as an activity that induced early eyelid opening, incisor eruption, hair growth inhibition, and stunting of growth when injected into newborn mice. EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor) .Recombinant mouse Epidermal Growth Factor (rmEGF) produced in E.coli is a single non-glycosylated polypeptide chain containing 54 amino acids. A fully biologically active molecule, rmEGF is obtained by proprietary chromatographic techniques at GenScript with a molecular mass of 6.2kDa analyzed by reducing SDS-PAGE.
Product Name Alternative
Epidermal Growth Factor
Source
Escherichia coli.
Endotoxin
< 0.2 EU/μg, determined by LAL method.
Purity
> 95% by SDS-PAGE and HPLC analysis.
Bioactivity
ED50 1.0x 10ˆ7units/mg.
Form
Lyophilized after extensive dialysis against PBS.
Molecular Weight
6.2 kDa, observed by reducing SDS-PAGE.
Storage Conditions
Lyophilized recombinant mouse Epidermal Growth Factor (rmEGF) remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, rmEGF should be stable up to 2 weeks at 4°C or up to 3 months at -20°C.
Notes
For research use only.
Applications Notes
Reconstituted in ddH2O at 100 μg/ml.
Preservative
Lyophilized after extensive dialysis against PBS.
AA Sequence
MNSYPGCPS SYDGYCLNGG VCMHIESLDS YTCNCVIGYS GDRCQTRDLR WWELR